We are live on ! Find out more
AI

Axiom Investors Portfolio holdings

AUM $8.99B
1-Year Est. Return 44.68%
This Fund
S&P 500
This Quarter Est. Return
+19.91%
1 Year Est. Return
+44.68%
3 Year Est. Return
+214.21%
5 Year Est. Return
+302.8%
10 Year Est. Return
+1,834.44%
AUM
$6.34B
AUM Growth
+$181M
Cap. Flow
-$611M
Cap. Flow %
-9.63%
Top 10 Hldgs %
42.99%
Holding
141
New
29
Increased
38
Reduced
55
Closed
16

Top Buys

Rank Stock Value
1
INFY icon
Infosys
INFY
+$107M
2
ITUB icon
Itaú Unibanco
ITUB
+$96.9M
3
AMD icon
Advanced Micro Devices
AMD
+$59.9M
4
STM icon
STMicroelectronics
STM
+$43.7M
5
NIO icon
NIO
NIO
+$43.4M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$385M
2
JD icon
JD.com
JD
+$190M
3
TSM icon
TSMC
TSM
+$119M
4
MSFT icon
Microsoft
MSFT
+$82.1M
5
AZN icon
AstraZeneca
AZN
+$73M

Sector Composition

Rank Sector Weight
1 Technology 40.84%
2 Consumer Discretionary 26.2%
3 Financials 7.68%
4 Industrials 7.5%
5 Healthcare 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMIN icon
76
iShares MSCI India Small-Cap ETF
SMIN
$771M
$7.05M 0.11%
166,600
FRPT icon
77
Freshpet
FRPT
$3.25B
$6.9M 0.11%
48,622
-42,123
-46% -$5.44M
SLAB icon
78
Silicon Laboratories
SLAB
$7.21B
$6.9M 0.11%
54,157
+11,853
+28% +$1.34M
WING icon
79
Wingstop
WING
$3.16B
$6.63M 0.1%
50,005
+728
+1% +$95K
HLNE icon
80
Hamilton Lane
HLNE
$5.51B
$6.43M 0.1%
82,429
+822
+1% +$59.6K
BLD
81
DELISTED
TopBuild
BLD
$6.38M 0.1%
34,683
-27,930
-45% -$4.94M
PGNY icon
82
Progyny
PGNY
$2.2B
$6.29M 0.1%
148,278
+28,304
+24% +$921K
AFYA icon
83
Afya
AFYA
$1.23B
$5.97M 0.09%
+236,060
New +$6.08M
ADUS icon
84
Addus HomeCare
ADUS
$2.24B
$5.66M 0.09%
48,309
+21,429
+80% +$2.21M
VC icon
85
Visteon
VC
$2.79B
$5.63M 0.09%
+44,897
New +$4.73M
HALO icon
86
Halozyme
HALO
$12.2B
$5.58M 0.09%
+130,750
New +$4.7M
REXR icon
87
Rexford Industrial Realty
REXR
$8.1B
$5.46M 0.09%
111,275
+37,277
+50% +$1.81M
NOVT icon
88
Novanta
NOVT
$6.2B
$5.31M 0.08%
44,923
+7,521
+20% +$877K
NVMI
89
Nova
NVMI
$12.4B
$4.97M 0.08%
70,356
+26,890
+62% +$1.67M
MRCY icon
90
Mercury Systems
MRCY
$6.48B
$4.35M 0.07%
49,425
-9,464
-16% -$719K
FSS icon
91
Federal Signal
FSS
$7.73B
$4.34M 0.07%
130,750
-2,508
-2% -$79.2K
RBC icon
92
RBC Bearings
RBC
$17.6B
$4.28M 0.07%
23,922
+14,732
+160% +$2.25M
TPIC
93
DELISTED
TPI Composites
TPIC
$4.05M 0.06%
+76,760
New +$3.07M
FFIN icon
94
First Financial Bankshares
FFIN
$4.9B
$4.04M 0.06%
111,640
+78,097
+233% +$2.56M
CSTL icon
95
Castle Biosciences
CSTL
$1B
$3.88M 0.06%
+57,825
New +$3.13M
PAR icon
96
PAR Technology
PAR
$738M
$3.87M 0.06%
+61,640
New +$3.03M
SF
97
Stifel
SF
$12.7B
$3.82M 0.06%
113,532
+42,506
+60% +$1.26M
UCB
98
United Community Banks
UCB
$4.25B
$3.66M 0.06%
128,695
+86,351
+204% +$2.04M
MSA icon
99
Mine Safety
MSA
$7.45B
$3.62M 0.06%
24,235
-4,753
-16% -$686K
JBTM
100
JBT Marel
JBTM
$6.24B
$3.62M 0.06%
31,765
-11,000
-26% -$1.13M

Similar funds

Axiom Investors's Q4 2020 Portfolio in Review

As of Q4 2020, Axiom Investors held 141 positions worth $6.34B, up 2.9% from $6.16B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Axiom Investors withdrew a net $611M in Q4 2020, closing 16 positions and reducing 55 holdings. Its most notable exit was AstraZeneca, an estimated $73M position sold in full.

By sector, the portfolio is most concentrated in Technology at 41% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Axiom Investors opened a new position in Infosys worth $119M.

  • Axiom Investors's largest Q4 2020 buy was Infosys: 7,014,800 shares worth $119M.
  • Axiom Investors added most to Generac Holdings in Q4 2020, an estimated $42.4M increase.
  • Axiom Investors's biggest Q4 2020 reduction was Alibaba, cutting an estimated $385M.
  • Axiom Investors fully exited AstraZeneca in Q4 2020, selling an estimated $73M.
  • Axiom Investors's ten largest holdings make up 43% of its $6.34B portfolio in Q4 2020.
  • Axiom Investors opened 29 new positions and closed 16 in Q4 2020.
  • Axiom Investors's portfolio value rose 2.9% quarter-over-quarter to $6.34B.

Based on Axiom Investors's 13F filing for Q4 2020, filed 12 Feb 2021.